WR-1065, the active metabolite of amifostine (ethyol®), does not inhibit the cytotoxic effects of a broad range of standard anticancer drugs against human ovarian and breast cancer cells

D. S. Alberts, L. A. Speicher, M. Krutzsch, J. Wymer, R. L. Capizzi, J. Conlon, A. Barrett, M. Aickin

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'WR-1065, the active metabolite of amifostine (ethyol®), does not inhibit the cytotoxic effects of a broad range of standard anticancer drugs against human ovarian and breast cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences